Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4724 total record number 96 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 15 out of 473
4724 citations found

Integrin α3 promotes TH17 cell polarization and extravasation during autoimmune neuroinflammation

Park, E;Barclay, WE;Barrera, A;Liao, TC;Salzler, HR;Reddy, TE;Shinohara, ML;Ciofani, M;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

NK Receptors Replace CD28 As the Dominant Source of Signal 2 for Cognate Recognition of Cancer Cells by TAA-specific Effector CD8+ T Cells

Dong, B;Obermajer, N;Tsuji, T;Matsuzaki, J;Bonura, C;Withers, H;Long, M;Chavel, C;Olejniczak, SH;Minderman, H;Edwards, RP;Storkus, WJ;Romero, P;Kalinski, P;

Product: Enterotoxin Type B from Staphylococcus aureus

  • Staphylococcus Enterotoxin B (SEB) was purchased from List Labs; …

Anthrax lethal toxin and tumor necrosis factor-α synergize on intestinal epithelia to induce mouse death

Gao, X;Teng, T;Liu, Y;Ai, T;Zhao, R;Fu, Y;Zhang, P;Han, J;Zhang, Y;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Product: Botulinum Neurotoxin Type A from Clostridium botulinum

Autotaxin in encephalitogenic CD4 T cells as a therapeutic target for multiple sclerosis

Petersen-Cherubini, CL;Murphy, SP;Xin, M;Liu, Y;Deffenbaugh, JL;Jahan, I;Rau, CN;Yang, Y;Lovett-Racke, AE;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation

Bowen, EE;Hurcombe, JA;Barrington, F;Keir, LS;Farmer, LK;Wherlock, MD;Ortiz-Sandoval, CG;Bruno, V;Bohorquez-Hernandez, A;Diatlov, D;Rostam-Shirazi, N;Wells, S;Stewart, M;Teboul, L;Lay, AC;Butler, MJ;Pope, RJP;Larkai, EMS;Morgan, BP;Moppett, J;Satchell, SC;Welsh, GI;Walker, PD;Licht, C;Saleem, MA;Coward, RJM;

Product: Shiga Toxin 2 from Escherichia coli

  • Product #162L – Shiga Toxin 2 from Escherichia coli

    Shiga toxin work

    Shiga toxin 2 (Stx2) was obtained commercially from the USA through List Biological Laboratories Inc. (product #162 lot 1621A1). Stx2 was chosen as it is known to be more cytotoxic in mice than Stx1; and because epidemiological data from human studies have demonstrated that Stx2 producing STEC have a stronger association with more severe disease.22 All work involving the toxin was performed in a biological cabinet under category 3 facilities. Prior to any toxin work commencing, a ‘control of substances hazardous to health regulations’ (COSHH) risk assessment was completed which was submitted and reviewed by the biological and genetic safety committee.

    Upon receipt of Shiga toxin, the lyophilized powder was reconstituted with 100μL distilled water and gently mixed by inversion in-keeping with the manufacturer’s instructions. This resulted in a stock concentration of 10μg/100μls which was aliquoted into 20μL stock eppendorfs and stored at −20°C until use. The toxin was assessed for purity on 12% SDS-PAGE and was found to have two major bands at molecular weights of 33 kDa and 8 kDa corresponding to A and B toxin subunits, respectively. Purity was >98% and the endotoxin content determined on kinetic chromogenic LAL assay at List Labs was <90EU/mg. A dose of 10 ng/g of Shiga toxin diluted in sterile normal saline 0.9% (Baxter) was given to each mouse via intraperitoneal injection. All in vitro Shiga toxin cell treatments were performed on differentiated cells at a dose of 0.1 ng/ml.

Evaluation of an in vitro experimental platform of human polarized intestinal epithelial monolayers for the hazard assessment of insecticidal proteins

Zimmermann, CS;Snow, RF;Wilson-Mifsud, B;LeRoy, K;Boeckman, C;Huang, E;Mathesius, CA;Roper, JM;Hurley, BP;

Product: Toxin B from Clostridium difficile

  • 2.1. Materials

    E. coli Shiga toxin 1 Stx1 enterotoxin List Laboratories #161 0.2, 1, 2 μg/ml
    Clostridium difficile Toxin B ToxB enterotoxin List Laboratories #155B 0.2, 1, 2 μg/ml
    Clostridium difficile Toxin A ToxA enterotoxin List Laboratories #152B 2 μg/ml

    2.4. Exposure to proteins

    … Four IEC monolayers/treatment group were exposed to (−) control media alone, (+) control Clostridium difficile Toxin A, (+) control TritonX-100, individual test proteins at three different concentrations, or a mixture of the two-component insecticidal protein (AfIP-1A + AfIP-1B) at three different concentrations. The concentrations of the proteins added were based primarily on the solubility of the protein and/or the amount that were commercially available. …

    Product #161 – Shiga Toxin 1 from Escherichia coli
    Product #155 – Toxin B from Clostridium difficile
    Product #152C – Toxin A from Clostridium difficile

Remyelination protects neurons from DLK-mediated neurodegeneration

Duncan, GJ;Ingram, SD;Emberley, K;Hill, J;Cordano, C;Abdelhak, A;McCane, M;Jabassini, N;Ananth, K;Ferrara, SJ;Stedelin, B;Sivyer, B;Aicher, SA;Scanlan, T;Watkins, TA;Mishra, A;Nelson, J;Green, AJ;Emery, B;

Product: Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

  • EAE induction

    Experimental autoimmune encephalomyelitis (EAE) was induced in eight week-old female C57BL/6 mice via immunization with myelin oligodendrocyte glycoprotein (MOG)35–55 (PolyPeptide Laboratories). 200 μg MOG35–55 was dissolved in complete Freund’s adjuvant containing 400 μg of Mycobacterium tuberculosis (231141, Difco) and injected subcutaneously in 0.2mL volume per mouse. Pertussis toxin (181, List Biological labs Inc) was administered via intraperitoneal injection after the MOG 35–55 injection and two days later at 75ng and 200ng per mouse doses, respectively.

    Product #181 – Pertussis Toxin from B. pertussis, Lyophilized (Salt-Free)

Tafluprost promotes axon regeneration after optic nerve crush via Zn2+-mTOR pathway

Wu, S;Liu, C;Tang, J;Wu, C;Zhang, Q;Liu, Z;Han, J;Xue, J;Lin, J;Chen, Y;Yang, J;Zhuo, Y;Li, Y;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

Teriflunomide Promotes Blood-Brain Barrier Integrity by Upregulating Claudin-1 via the Wnt/?-catenin Signaling Pathway in Multiple Sclerosis

Zhao, Y;Chen, C;Xiao, X;Fang, L;Cheng, X;Chang, Y;Peng, F;Wang, J;Shen, S;Wu, S;Huang, Y;Cai, W;Zhou, L;Qiu, W;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer